DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Neuland Laboratories Limited
03 1Farmhispania, S.A.
04 1AX Pharmaceutical Corp
05 1DARMERICA, LLC
06 1LETCO MEDICAL, LLC
07 1Medisca Inc.
08 1Professional Compounding Centers of America dba PCCA
09 1Spectrum Laboratory Products, Inc.
10 1Srini Pharmaceuticals Private Limited
11 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 1ENALAPRIL MALEATE
02 10Enalapril Maleate
01 1Canada
02 1China
03 3India
04 1Spain
05 4U.S.A
06 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-008
Start Marketing Date : 1998-11-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-0125
Start Marketing Date : 2017-11-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
NDC Package Code : 17404-0009
Start Marketing Date : 2000-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-103
Start Marketing Date : 2021-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2769
Start Marketing Date : 2009-09-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0514
Start Marketing Date : 2014-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-3336
Start Marketing Date : 2013-06-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-2706
Start Marketing Date : 1998-05-01
End Marketing Date : 2026-07-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66174-0074
Start Marketing Date : 2015-02-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-143
Start Marketing Date : 2008-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Kinfil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kinfil, including repackagers and relabelers. The FDA regulates Kinfil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kinfil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Kinfil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Kinfil supplier is an individual or a company that provides Kinfil active pharmaceutical ingredient (API) or Kinfil finished formulations upon request. The Kinfil suppliers may include Kinfil API manufacturers, exporters, distributors and traders.
click here to find a list of Kinfil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Kinfil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Kinfil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Kinfil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Kinfil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Kinfil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Kinfil suppliers with NDC on PharmaCompass.
We have 11 companies offering Kinfil
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
